These results show that N-cadherin activates the ErbB signaling pathway to regulate the EMT and stemness of prostate cancer cells, indicating a central role of the N-cadherin/ErbB axis in the progression of prostate cancer metastasis. The gene discussed is CDH2; the disease is prostate carcinoma.